# Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study

> **NCT01136980** · NA · COMPLETED · sponsor: **EndoGastric Solutions** · enrollment: 129 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease
- Hiatal Hernia

## Interventions

- **DEVICE:** TIF Transoral Fundoplication
- **OTHER:** Sham placebo procedure

## Key facts

- **NCT ID:** NCT01136980
- **Lead sponsor:** EndoGastric Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2015-04
- **Final completion:** 2018-03
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2021-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01136980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01136980, "Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01136980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*